US Patent Issued to INSERM (Institut National de la Sante et de la Recherche Medicale), Universite de Paris, UNIVERSITE PARIS-SACLAY, UNIVERSITE PARIS XIII PARIS-NORD on July 7 for "Anti-protease nexin-1 conformational single domain antibodies and uses thereof to control bleeding" (French Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,986, issued on July 7, was assigned to INSERM (Institut National de la Sante et de la Recherche Medicale) (Paris), Universite de Paris (Paris), UNIVERSITE PARIS-SACLAY (Gif-sur-Yvette, France) and UNIVERSITE PARIS XIII PARIS-NORD (Villetaneuse, France).

"Anti-protease nexin-1 conformational single domain antibodies and uses thereof to control bleeding" was invented by Olivier Christophe (le Kremlin-Bicetre, France), Peter Lenting (le Kremlin-Bicetre, France), Cecile Denis (le Kremlin-Bicetre, France) and Marie-Christine Bouton (Paris Cedex, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Protease nexin-1 (PN-1) is a member of the serine proteas...